Research study Program year 2025 Source: CMS Open Payments

A Phase I/II, Randomized, Open-Label Platform Study Utilizing A Master

Research payments

$3,907,748

435 payments

Through program year 2025, $3,907,748 in research payments was reported against A Phase I/II, Randomized, Open-Label Platform Study Utilizing A Master, across 435 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$284,550	95
2024	Research	$843,889	60
2023	Research	$1,163,684	115
2022	Research	$981,805	93
2021	Research	$600,130	62
2020	Research	$33,689	10

Breakdown

Who paid Research payments · program years 2020–2025

GlaxoSmithKline, LLC. $3,907,748 435 payments

Who received the money Research payments · program years 2020–2025

Dana Farber Partners Cancer Care INC Organisation paid for research $1,196,545 51 payments
University Of Wisconsin Organisation paid for research $972,393 44 payments
Emory University Organisation paid for research $849,205 155 payments
University Of Wisconsin And Visual Sciences Organisation paid for research $305,449 44 payments
Dana Farber Partners Cancer Organisation paid for research $195,610 31 payments
Multiple Doctors Organisation paid for research $113,181 39 payments
Dana Farber Cancer Institute INC Organisation paid for research $109,483 9 payments
Indiana University Organisation paid for research $106,546 39 payments
University of Texas Health Science Center at San Antonio Organisation paid for research $23,810 9 payments
Rush University Medical Center Organisation paid for research $22,870 4 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.